Value Proposition.
Embedded.
Similar to a full-time hire, Fred completely immerses himself in the teams he partners with for the entire duration of the project. The benefits to the company are significant since this type of collaboration creates a seamless augmentation of the existing skills and capabilities of the team, a smooth integration of the workflow and work products, a strong sense of shared ownership by all team members, and ultimately a greater impact on the company.
Flexible.
While most biotech companies need senior expertise in Business Development, Strategy, and Portfolio Prioritization at certain points in their development, such expertise is often not needed at all times. To make the most of financial resources and optimize the use of human capital, leveraging a part-time senior expert provides a flexible, cost-effective, and targeted way to resource these critical initiatives while accessing deep experience and capabilities.
Tailored.
Business Development, Strategy, and Prioritization projects all have varying needs and unique circumstances. Biotech companies also differ in the range of skills, capabilities, and bandwidth available internally. Whether the project lasts 3 months or 12+ months, Fred flexes his time to ensure that the project gets the amount of support it needs. Fred also tailors his contribution to make sure that the expertise and support he brings appropriately complement the skills and capabilities available in the organization.
Seasoned.
Many biotechnology companies aspire to become commercial-stage and/or to partner with large pharma players to maximize the commercial potential of their innovation. Having worked with global pharmaceutical and biotech companies, Fred understands what these players are looking for. Leveraging his broad industry experience and insights, Fred is able to help his clients most effectively navigate the partnering process so that time and resources are focused on the right activities in order to increase the likelihood of executing a deal.